Join your colleagues in sharing innovative approaches to clinical practice, gaining insight into transplant finance, and expanding your leadership skills at the AST Medical Directors Forum.

Registration for the Fellows Symposium on Transplantation is now open! This comprehensive program is designed for clinical fellows and residents, surgical fellows, research fellows, pharmacists, and other trainees planning a career in transplantation medicine, surgery, or research.

Fellows, residents, trainees, and pharmacists who meet the eligibility criteria can apply for a travel grant. Fellows who are ineligible for travel grants may still register as general attendees. Medical students are also welcome to attend. The deadline to apply for a travel grant is July 1. Please encourage your colleagues to apply.

On behalf of the AST, the European Society for Organ Transplantation (ESOT), and The Transplantation Society (TTS), we are excited to announce that registration is officially open for the International Transplantation Science Meeting 2025. 

ITS 2025 marks the fourth tri-society event in this global collaboration, bringing together top experts, early-career researchers, and transplant professionals worldwide. This meeting offers an exciting forum to explore cutting-edge basic and translational science in and beyond the field of transplantation.

We’re excited to introduce the AST Mentorship Program, a new member benefit designed to foster meaningful, career-shaping connections across the transplant community.

Whether you're looking to give back as a mentor or grow as a mentee, this program supports all transplant professionals — including students and trainees — with a flexible structure that fits your schedule and preferred way to connect: remote, hybrid, or in-person.

Help shape AST’s work by taking our quick, anonymous member survey. Your feedback will guide our priorities and strengthen support for the transplant community. It only takes a few minutes — and you could win one of ten $50 Amazon gift cards! The deadline to complete the survey is Monday, June 16.

Students can join the AST for just $29 now through June 30! This limited-time offer is a great opportunity to connect with leaders in the field, access valuable educational resources, and explore a future in transplantation.

Know a student who might be interested? Please share this with your network!

The AST is compiling a centralized list of transplant fellowship programs to better support early-career clinicians, researchers, and trainees exploring careers in transplantation. This directory will be a valuable tool for those seeking information on training opportunities in organ transplantation.

If you're affiliated with a transplant fellowship program, we invite you to submit your program for inclusion. Your participation will help us develop a meaningful and accessible resource for individuals in transplantation.

We’re excited to launch a new Affiliate Membership designed specifically for business professionals who want to connect with the transplant community. Affiliate Membership is the perfect way to stay connected, enhance your career, and take full advantage of what our organization has to offer. 

The Living Donor Protection Act (LDPA) has been reintroduced in Congress, and we need your support. This bipartisan legislation would prohibit insurance discrimination against living organ donors, ensure they can use FMLA leave during recovery, and require updated educational resources to promote donation.

Take action now — urge your lawmakers to support the LDPA.

Funding cuts to the National Institutes of Health (NIH) put critical transplant research at risk. NIH-funded studies have driven advancements in transplantation, improving patient outcomes and paving the way for innovations like new immunosuppressants, immune tolerance strategies, and even organ regeneration. Without this support, progress in the field could slow, affecting countless patients and families.

We need your help to ensure that transplant research remains a priority. Use our advocacy page to contact your members of Congress and urge them to protect NIH funding. Together, we can make a difference. Take action today!

The AST developed a survey aimed at soliciting your perspectives on legislative and regulatory issues that significantly influence both patient care and professional practice. Our goal is to establish a platform for our membership to share their invaluable ideas and perspectives and actively engage with the Public Policy Committee and AST leadership. We look forward to your input as we navigate the dynamics of our ever-evolving landscape of transplant care and practice.

Nonuse of expanded criteria donor (ECD) kidneys from donation after cardiocirculatory death (DCD) donors remains high. The study purpose was to analyze our experience with kidney transplantation (KT) from DCD donors stratified by ECD versus non-ECD (standard criteria donor [SCD]).

Liver transplant is indicated in patients with Wilson's disease for acute hepatic failure, advanced cirrhosis, and disease refractory to chelation therapy. This study aims to systematically review data about overall morbidity, hepatic, neuropsychiatric, and survival outcomes following liver transplantation for Wilson disease.

Lung transplantation remains the only curative treatment option for patients with end-stage lung disease, yet limited donor lung availability and utilization remains a significant obstacle. The ex vivo lung perfusion (EVLP) system allows for the extension of the donor assessment, providing the opportunity to perform advanced assessment on the isolated donor lung under near-physiological conditions. 

Immunosuppressant medications, such as tacrolimus and mycophenolate mofetil (MMF), are crucial for preventing graft rejection after heart transplantation (HTx). Generic formulations have become available, offering potential cost savings, but concerns exist regarding their clinical bioequivalence compared to brand-name formulations. Current guidelines suggest no increased risk with generic use, but research remains limited. Therefore, this study aims to explore whether the type of immunosuppressant formulation at hospital discharge influences post-transplant outcomes.